FDA probes TNF blockers.
Huggett
Brady
B
D000293:Adolescent; D018501:Antirheumatic Agents / Q000009:adverse effects*; D002648:Child; D006801:Humans; D009369:Neoplasms / Q000209:etiology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*; D014481:United States; D014486:United States Food and Drug Administration
D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha